{"data":{"id":"us-dc/d.c.-code-28-4552","jurisdiction":"us-dc","citation":"D.C. Code § 28-4552","heading":"Definitions.","body":"For the purposes of this chapter, the term:\n\n(1)\n“Affected party” means any person directly or indirectly affected by excessive prices of patented prescription drugs, including any organization representing such persons or any person or organization representing the public interest.\n\n(2)\n“High income country” means the United Kingdom, Germany, Canada, or Australia.","path":["Title 28. Commercial Instruments and Transactions. [Enacted title]","Chapter 45B. Excessive Pricing."],"source_url":"https://code.dccouncil.gov/us/dc/council/code/sections/28-4552","current_through":"2026-08-20 (D.C. Law 26-175)","vintage":"","retrieved_at":"2026-08-29T05:44:07Z","sha256":"52b9d29410118d170a2b4db2b5d653ae65b8f6b0786704a6b295189d57918081","source_id":"us-dc","stale":false,"prev":"us-dc/d.c.-code-28-4551","next":"us-dc/d.c.-code-28-4553"},"notice":"GroundRules: Original legal text. Not legal advice."}